Cancer nanomedicine: Recent developments in drug delivery systems and strategies to overcome eventual barriers to achieve a better outcome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer nanomedicine: Recent developments in drug delivery systems and strategies to overcome eventual barriers to achieve a better outcome

Published:2024-01 Issue: Volume:91 Page:105254
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Henn Jeferson Gustavo^ORCID,Aguirre Tanira Alessandra Silveira^ORCID,Nugent Michael^ORCID,Moura Dinara Jaqueline^ORCID

Funder

Fundação de Apoio à Pesquisa do Rio Grande do Norte

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference252 articles.

1. Imatinib: A Viewpoint by Brian J. Druker. Drugs;Druker,2001

2. Genomic instability – an evolving hallmark of cancer;Negrini;Nat. Rev. Mol. Cell Biol.,2010

3. Influence of tumour micro-environment heterogeneity on therapeutic response;Junttila;Nature,2013

4. Nanomedicines for cancer therapy: current status, challenges and future prospects;Bor;Ther. Deliv.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advancements in Metallic Au- and Ag-Based Chitosan Nanocomposite Derivatives for Enhanced Anticancer Drug Delivery;Molecules;2024-05-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP